Volume 29, Number 5—May 2023
Dispatch
Characteristics and Treatment of Gordonia spp. Bacteremia, France
Alia Barthel1, Axel Ursenbach1, Charlotte Kaeuffer1, Christelle Koebel, Alain Gravet, Dominique De Briel, Jacqueline Dubois, Elina Haerrel, Estelle Rougier2, and Victor Gerber13
Table 2
Characteristics of patients with Gordonia bacteremia, 2010–2021, France*
| Variables | No. (%) |
|---|---|
| Median age, y (range) |
49 (0.25–86.0) |
| Sex, n = 10 | |
| M | 6 (60.0) |
| F |
4 (40.0) |
| Immunodeficiency factors, n = 7 | |
| Corticosteroids | 3 (42.8) |
| Severe malnutrition | 4 (57.1) |
| Hemodialysis | 2 (28.6) |
| Hemopathy | 2 (28.6) |
| Transplantation | 2 (28.6) |
| HIV |
2 (28.6) |
| Central venous catheter, n = 6 | |
| Central port | 3 (50.0) |
| Other central catheter |
3 (50.0) |
| Nosocomial infection,* n = 10 | |
| Y | 3 (30.0) |
| N |
7 (70.0) |
| Microbiological identification, n = 10 | |
| G. bronchialis | 2 (20.0) |
| G. sputi | 4 (40.0) |
| G. aichiensis |
1 (10.0) |
| Antimicrobial therapy, n = 9 | |
| 3rd/4th-generation cephalosporin | 6 (66.6) |
| β-lactam with β-lactamase inhibitor | 4 (44.4) |
| Glycopeptide | 3 (33.3) |
| Penicillin | 2 (22.2) |
| Aminoside | 2 (22.2) |
| Carbapenem | 1 (11.1) |
| Fluoroquinolone |
1 (11.1) |
| Median treatment duration, d (range) |
15 (0–35) |
| CVC ablation, n = 6 |
3 (50.0) |
| Outcome, n = 10 | |
| Favorable outcome† | 8 (80.0) |
| Relapse‡ | 2 (20.0) |
*Clinical signs of infection starting >48 h after hospitalization †Favorable outcome required clinical and biologic cure and repeated negative blood sample, without relapse through the end of the study period (May 31, 2022). ‡Relapse without cure through May 31, 2022.
1These authors contributed equally to this article.
2Current affiliation: Hôpital Saint-Antoine, Assistance Publique des Hôpitaux de Paris, Paris, France.
3Current affiliation: Hôpitaux universitaires de Strasbourg, Strasbourg, France.
Page created: March 01, 2023
Page updated: April 19, 2023
Page reviewed: April 19, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.